We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.48%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.62B
AUM Growth
-$84.4M
Cap. Flow
-$358M
Cap. Flow %
-9.89%
Top 10 Hldgs %
26.83%
Holding
5,773
New
537
Increased
1,570
Reduced
3,043
Closed
580

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$46.2M
2
MSFT icon
Microsoft
MSFT
+$46.2M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$40M
4
NVDA icon
NVIDIA
NVDA
+$27.6M
5
PLTR icon
Palantir
PLTR
+$27.6M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 7.48%
3 Consumer Discretionary 6.48%
4 Healthcare 6.28%
5 Communication Services 6.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XCUR icon
4051
Exicure
XCUR
$8.8M
$8.31K ﹤0.01%
2,032
+1,057
+108% +$6.36K
GRI
4052
GRI Bio
GRI
$3.9M
$8.29K ﹤0.01%
144
+7
+5% +$324
GUTS icon
4053
Fractyl Health
GUTS
$110M
$8.28K ﹤0.01%
5,209
+2,414
+86% +$3.13K
RVPH
4054
DELISTED
REVIVA PHARMA HLDGS INC
RVPH
$8.26K ﹤0.01%
1,121
+1,050
+1,479% +$8.92K
KSPI icon
4055
Kaspi.kz JSC
KSPI
$18.3B
$8.25K ﹤0.01%
101
-99
-50% -$8.67K
QUIK icon
4056
QuickLogic
QUIK
$229M
$8.24K ﹤0.01%
1,360
-5,531
-80% -$32.7K
BHK icon
4057
BlackRock Core Bond Trust
BHK
$662M
$8.24K ﹤0.01%
+829
New +$8.03K
BAK icon
4058
Braskem
BAK
$877M
$8.23K ﹤0.01%
3,400
+2,681
+373% +$8.6K
ALTO icon
4059
Alto Ingredients
ALTO
$320M
$8.18K ﹤0.01%
7,576
+2,841
+60% +$3.19K
ULBI icon
4060
Ultralife
ULBI
$120M
$8.17K ﹤0.01%
1,198
-2,081
-63% -$15.8K
OSTX
4061
OS Therapies Inc
OSTX
$72.5M
$8.17K ﹤0.01%
4,167
+1,617
+63% +$3.2K
SIF icon
4062
SIFCO Industries
SIF
$121M
$8.15K ﹤0.01%
1,157
+727
+169% +$4.34K
ORGN
4063
DELISTED
Origin Materials
ORGN
$8.13K ﹤0.01%
522
+356
+214% +$6.61K
AYTU icon
4064
AYTU BioPharma
AYTU
$25.5M
$8.13K ﹤0.01%
4,323
+1,785
+70% +$4.13K
BF.A icon
4065
Brown-Forman Class A
BF.A
$12.9B
$8.1K ﹤0.01%
301
-260
-46% -$7.56K
SLE icon
4066
Super League Enterprise
SLE
$5.39M
$8.08K ﹤0.01%
+150
New +$7.77K
SMXT icon
4067
Solarmax Technology
SMXT
$20.1M
$8.05K ﹤0.01%
7,670
-11,142
-59% -$12.3K
HYPR icon
4068
Hyperfine
HYPR
$95.1M
$8.01K ﹤0.01%
5,527
+5,507
+27,535% +$6.43K
LNAI
4069
Lunai Bioworks
LNAI
$10.5M
$7.99K ﹤0.01%
703
+1
+0.1% +$19
NEWP
4070
New Pacific Metals
NEWP
$1.23B
$7.98K ﹤0.01%
+2,943
New +$5.47K
NUTR
4071
Nusatrip Inc
NUTR
$7.96K ﹤0.01%
+998
New +$5.26K
APYX icon
4072
Apyx Medical
APYX
$126M
$7.96K ﹤0.01%
+3,721
New +$7.88K
CFLT
4073
DELISTED
Confluent
CFLT
$7.92K ﹤0.01%
400
-121
-23% -$2.53K
AMST icon
4074
Amesite
AMST
$6.75M
$7.91K ﹤0.01%
2,593
+1,299
+100% +$3.91K
JAGX icon
4075
Jaguar Health
JAGX
$3.98M
$7.88K ﹤0.01%
106
+56
+112% +$3.79K

Similar funds

Tower Research Capital (TRC)'s Q3 2025 Portfolio in Review

As of Q3 2025, Tower Research Capital (TRC) held 5,773 positions worth $3.62B, down 2.3% from $3.71B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Tower Research Capital (TRC) withdrew a net $358M in Q3 2025, closing 580 positions and reducing 3,043 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $23.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in JPMorgan Ultra-Short Income ETF worth $30.6M.

  • Tower Research Capital (TRC)'s largest Q3 2025 buy was JPMorgan Ultra-Short Income ETF: 603,010 shares worth $30.6M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2025, an estimated $254M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2025 reduction was Apple, cutting an estimated $46.2M.
  • Tower Research Capital (TRC) fully exited Vanguard S&P 500 ETF in Q3 2025, selling an estimated $23.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 27% of its $3.62B portfolio in Q3 2025.
  • Tower Research Capital (TRC) opened 537 new positions and closed 580 in Q3 2025.
  • Tower Research Capital (TRC)'s portfolio value fell 2.3% quarter-over-quarter to $3.62B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2025, filed 14 Nov 2025.